Literature DB >> 11594455

Lung transplantation and bronchiolitis obliterans: an evolution in understanding.

B W McKane1, E P Trulock, G A Patterson, T Mohanakumar.   

Abstract

Major advancements in the field of lung transplantation have occurred over the past thirty-five years. Despite these advancements, limitations in our ability to obtain sufficient numbers of organs and in our comprehension of the problems associated with the procedure persist. The purpose of this article is to review the current understanding of both the surgical procedure and its most unfortunate complication, bronchiolitis obliterans. Even now, after over three decades of experience, this complication remains the most significant cause of morbidity and mortality following lung transplantation. This article is not meant to be an exhaustive review, and certainly there are important topics not covered herein. We have focused the discussion on ongoing studies, which attempt to understand bronchiolitis obliterans at both the clinical as well as the immunopathological level.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594455     DOI: 10.1385/IR:24:2:177

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  53 in total

1.  Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.

Authors:  T J Kroshus; V R Kshettry; K Savik; R John; M I Hertz; R M Bolman
Journal:  J Thorac Cardiovasc Surg       Date:  1997-08       Impact factor: 5.209

2.  LUNG HOMOTRANSPLANTATION IN MAN.

Authors:  J D HARDY; W R WEBB; M L DALTON; G R WALKER
Journal:  JAMA       Date:  1963-12-21       Impact factor: 56.272

3.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation.

Authors:  G J Berry; E M Brunt; D Chamberlain; R H Hruban; R K Sibley; S Stewart; H D Tazelaar
Journal:  J Heart Transplant       Date:  1990 Nov-Dec

4.  The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report--1996.

Authors:  J D Hosenpud; R J Novick; L E Bennett; B M Keck; B Fiol; O P Daily
Journal:  J Heart Lung Transplant       Date:  1996-07       Impact factor: 10.247

5.  Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation.

Authors:  L L Schulman; A D Weinberg; C McGregor; M E Galantowicz; N M Suciu-Foca; S Itescu
Journal:  Am J Respir Crit Care Med       Date:  1998-06       Impact factor: 21.405

6.  The first transplantation of the lung in a human revisited.

Authors:  D A Blumenstock; C Lewis
Journal:  Ann Thorac Surg       Date:  1993-12       Impact factor: 4.330

7.  Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease.

Authors:  B A Reitz; J L Wallwork; S A Hunt; J L Pennock; M E Billingham; P E Oyer; E B Stinson; N E Shumway
Journal:  N Engl J Med       Date:  1982-03-11       Impact factor: 91.245

8.  Insulinlike growth factor-1 in lung transplants with obliterative bronchiolitis.

Authors:  J M Charpin; M Stern; D Grenet; D Israël-Biet
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

9.  Improved bronchial healing in canine left lung reimplantation using omental pedicle wrap.

Authors:  E Morgan; O Lima; M Goldberg; H Ayabe; A Ferdman; J D Cooper
Journal:  J Thorac Cardiovasc Surg       Date:  1983-01       Impact factor: 5.209

10.  Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.

Authors:  V G Valentine; R C Robbins; G J Berry; H R Patel; H Reichenspurner; B A Reitz; J Theodore
Journal:  J Heart Lung Transplant       Date:  1996-04       Impact factor: 10.247

View more
  2 in total

1.  The role of adenosine A2A receptor signaling in bronchiolitis obliterans.

Authors:  Christine L Lau; Yunge Zhao; Irving L Kron; Mark H Stoler; Victor E Laubach; Gorav Ailawadi; Joel Linden
Journal:  Ann Thorac Surg       Date:  2009-10       Impact factor: 4.330

2.  Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung.

Authors:  Hong D Chen; Armando E Fraire; Isabelle Joris; Raymond M Welsh; Liisa K Selin
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.